Adem Ozleyen

987 total citations · 1 hit paper
11 papers, 649 citations indexed

About

Adem Ozleyen is a scholar working on Molecular Biology, Ecology, Evolution, Behavior and Systematics and Plant Science. According to data from OpenAlex, Adem Ozleyen has authored 11 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Ecology, Evolution, Behavior and Systematics and 3 papers in Plant Science. Recurrent topics in Adem Ozleyen's work include Bioactive Compounds and Antitumor Agents (2 papers), Synthesis and biological activity (2 papers) and Plant and animal studies (2 papers). Adem Ozleyen is often cited by papers focused on Bioactive Compounds and Antitumor Agents (2 papers), Synthesis and biological activity (2 papers) and Plant and animal studies (2 papers). Adem Ozleyen collaborates with scholars based in Türkiye, Chile and Iran. Adem Ozleyen's co-authors include Tugba Boyunegmez Tumer, Javad Sharifi‐Rad, Miquel Martorell, Bahare Salehi, Jovana Rajković, Yakup Berkay Yılmaz, Rabin Gyawali, Zainul Amiruddin Zakaria, Tariq Khan and Lianet Monzote Fidalgo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Trends in Food Science & Technology.

In The Last Decade

Adem Ozleyen

10 papers receiving 632 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Piper Species: A Comprehensive Review on Their Phytochemistry, Biological Activities and Applications

2019 333 citations Bahare Salehi, Zainul Amiruddin Zakaria et al. Molecules profile →

Peers

Countries citing papers authored by Adem Ozleyen

Since Specialization

Citations

This map shows the geographic impact of Adem Ozleyen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adem Ozleyen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adem Ozleyen more than expected).

Fields of papers citing papers by Adem Ozleyen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adem Ozleyen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adem Ozleyen. The network helps show where Adem Ozleyen may publish in the future.

Co-authorship network of co-authors of Adem Ozleyen

This figure shows the co-authorship network connecting the top 25 collaborators of Adem Ozleyen. A scholar is included among the top collaborators of Adem Ozleyen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adem Ozleyen. Adem Ozleyen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Identification and inhibition of PIN1-NRF2 protein–protein interactions through computational and biophysical approaches 2025 ·Scientific Reports ·Adem Ozleyen, (unknown), (unknown), Mehmet Özbil, Richard G. Doveston, Tugba Boyunegmez Tumer	0
2	Looking at NSAIDs from a historical perspective and their current status in drug repurposing for cancer treatment and prevention 2022 ·Journal of Cancer Research and Clinical Oncology ·Adem Ozleyen, Yakup Berkay Yılmaz, (unknown), (unknown), Gizem Antika, Tugba Boyunegmez Tumer	28
3	Biofortified Whey/Deglycosylated Whey and Chickpea Protein Matrices: Functional Enrichment by Black Mulberry Polyphenols 2021 ·Plant Foods for Human Nutrition ·Adem Ozleyen, (unknown), Sercan Karav, (unknown), (unknown), (unknown), Bekir Salih, Tugba Boyunegmez Tumer	5
4	New nimesulide derivatives with amide/sulfonamide moieties: Selective COX-2 inhibition and antitumor effects 2021 ·European Journal of Medicinal Chemistry ·(unknown), Adem Ozleyen, Yakup Berkay Yılmaz, (unknown), Mehmet Ay, Serdar Durdağı, Tugba Boyunegmez Tumer	33
5	Dataset on the differentiation of THP-1 monocytes to LPS inducible adherent macrophages and their capacity for NO/iNOS signaling 2021 ·SHILAP Revista de lepidopterología ·Adem Ozleyen, Yakup Berkay Yılmaz, Tugba Boyunegmez Tumer	20
6	Multitarget Profiling of a Strigolactone Analogue for Early Events of Alzheimer’s Disease: In Vitro Therapeutic Activities against Neuroinflammation 2020 ·ACS Chemical Neuroscience ·(unknown), Adem Ozleyen, Gizem Antika, Yakup Berkay Yılmaz, Tugba Boyunegmez Tumer	17
7	Natural Products and Synthetic Analogs as a Source of Antitumor Drugs 2019 ·Biomolecules ·Javad Sharifi‐Rad, Adem Ozleyen, Tugba Boyunegmez Tumer, Charles Oluwaseun Adetunji, Nasreddine El Omari, Abdelaali Balahbib, Yasaman Taheri, Abdelhakim Bouyahya, Miquel Martorell, Natália Martins, William C. Cho	154
8	Plants of the genus Spinacia: From bioactive molecules to food and phytopharmacological applications 2019 ·Trends in Food Science & Technology ·Bahare Salehi, Tugba Boyunegmez Tumer, Adem Ozleyen, Gregorio Peron, Stefano Dall’Acqua, Jovana Rajković, Rabia Naz, (unknown), Fhatuwani N. Mudau, Fabiana Labanca, Luigi Milella, Nunziatina De Tommasi, Henrique Douglas Melo Coutinho, Javad Sharifi‐Rad, Deepa Verma, Miquel Martorell, Natália Martins	34
9	Piper Species: A Comprehensive Review on Their Phytochemistry, Biological Activities and Applications breakdown → 2019 ·Molecules ·Bahare Salehi, Zainul Amiruddin Zakaria, Rabin Gyawali, Salam A. Ibrahim, Jovana Rajković, Zabta Khan Shinwari, Tariq Khan, Javad Sharifi‐Rad, Adem Ozleyen, (unknown), Marco Valussi, Tugba Boyunegmez Tumer, Lianet Monzote Fidalgo, Miquel Martorell, William N. Setzer	333
10	In vitro and in silico studies of nitrobenzamide derivatives as potential anti-neuroinflammatory agents 2019 ·Journal of Biomolecular Structure and Dynamics ·(unknown), Ferah Cömert Önder, Yakup Berkay Yılmaz, Adem Ozleyen, Serdar Durdağı, Kader Şahin, Mehmet Ay, Tugba Boyunegmez Tumer	4
11	GR24, a synthetic analog of Strigolactones, alleviates inflammation and promotes Nrf2 cytoprotective response: In vitro and in silico evidences 2018 ·Computational Biology and Chemistry ·Tugba Boyunegmez Tumer, Yakup Berkay Yılmaz, Adem Ozleyen, (unknown), Tuğba Taşkın‐Tok, (unknown), (unknown)	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact